| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Sign In to gain access to subscriptions and/or personal tools.
|
|
|
|||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
From the Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
* Address correspondence to James H-C. Wang, Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, E1641 Biomedical Science Tower, 210 Lothrop Street, P.O. Box 71199, Pittsburgh, PA 15213 (e-mail: wanghc{at}pitt.edu).
Background: The cellular and molecular mechanisms for the development of tendinopathy are not clear, but inflammatory mediators produced by tendon fibroblasts in response to repetitive mechanical loading may be an important factor.
Hypotheses: (1) Cyclic stretching of tendon fibroblasts affects the production of leukotriene B4 and the expression of 5-lipoxygenase; and (2) the production level of leukotriene B4 is inversely related to that of prostaglandin E2.
Study Design: Controlled laboratory study.
Methods: Human patellar tendon fibroblasts were uniaxially stretched in the presence of indomethacin (25 µM) or MK-886 (10 µM). After stretching for 4 hours, followed by 4 hours rest, levels of prostaglandin E2, leukotriene B4, and expression of 5-lipoxygenase were measured.
Results: Stretched tendon fibroblasts increased the levels of leukotriene B4 but did not appreciably change the expression of 5-lipoxygenase. Indomethacin decreased the cellular production of prostaglandin E2 but caused increased leukotriene B4 levels. MK-886 caused decreased production of leukotriene B4 but increased production of prostaglandin E2.
Conclusions: Cyclic stretching of human tendon fibroblasts increases the production of prostaglandin E2 and leukotriene B4. Blocking prostaglandin E2 production leads to increased leukotriene B4 levels and vice versa.
Clinical Relevance: The use of nonsteroidal anti-inflammatory drugs for the treatment of tendon inflammation might increase the levels of leukotriene B4 within the tendon, potentially contributing to the development of tendinopathy.
Key Words: stretching • microgrooves • tendon fibroblasts • leukotriene B4 • 5-lipoxygenase
This article has been cited by other articles:
|
|
 |
|
  T. P. C. Kane, M. Ismail, and J. D. F. Calder Topical Glyceryl Trinitrate and Noninsertional Achilles Tendinopathy: A Clinical and Cellular Investigation Am. J. Sports Med., June 1, 2008; 36(6): 1160 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Nho, H. Yadav, M. K. Shindle, and J. D. MacGillivray Rotator Cuff Degeneration: Etiology and Pathogenesis Am. J. Sports Med., May 1, 2008; 36(5): 987 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Warden Animal models for the study of tendinopathy Br. J. Sports Med., April 1, 2007; 41(4): 232 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Molloy, M. W. Kemp, Y. Wang, and G. A. C. Murrell Microarray analysis of the tendinopathic rat supraspinatus tendon: glutamate signaling and its potential role in tendon degeneration J Appl Physiol, December 1, 2006; 101(6): 1702 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Rees, A. M. Wilson, and R. L. Wolman Current concepts in the management of tendon disorders Rheumatology, May 1, 2006; 45(5): 508 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J M Bjordal, R A B Lopes-Martins, V V Iversen, and R Chow A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations * Commentary Br. J. Sports Med., January 1, 2006; 40(1): 76 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C S Bestwick and N Maffulli Reactive oxygen species and tendinopathy: do they matter? Br. J. Sports Med., December 1, 2004; 38(6): 672 - 674. [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
